EASL Clinical Practice Guidelines: Management of chronic hepatitis B

被引：1345

作者：

Marcellin, Patrick ^{[1
]}

Dusheiko, Geoffrey ^{[1
]}

Zoulim, Fabien ^{[1
]}

Esteban, Rafael ^{[1
]}

Hadziyannis, Stefanos ^{[1
]}

Lampertico, Pietro ^{[1
]}

Manns, Michael ^{[1
]}

Shouval, Daniel ^{[1
]}

Yurdaydin, Cihan ^{[1
]}

机构：

[1] EASL Off, CH-1205 Geneva, Switzerland

来源：

JOURNAL OF HEPATOLOGY | 2009年 / 50卷 / 02期

关键词：

Hepatitis B virus; EASL guidelines; Treatment; Interferon alpha; Nucleoside/nucleotide analogues; ANTIGEN-NEGATIVE PATIENTS; DISOPROXIL FUMARATE TDF; ADEFOVIR DIPIVOXIL ADV; C-VIRUS COINFECTION; TENOFOVIR DF TDF; LAMIVUDINE TREATMENT; NATURAL-HISTORY; VIRAL-HEPATITIS; PEGINTERFERON ALPHA-2A; LIVER-TRANSPLANTATION;

D O I：

10.1016/j.jhep.2008.10.001

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

收藏

页码：227 / 242

页数：16

相关论文

共 109 条

[1] Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV co-infected patients [J].

Alberti, A ;

Clumeck, N ;

Collins, S ;

Gerlich, W ;

Lundgren, J ;

Palù, G ;

Reiss, P ;

Thiebaut, R ;

Weiland, O ;

Yazdanpanah, Y ;

Zeuzem, S .

JOURNAL OF HEPATOLOGY, 2005, 42 (05) :615-624

[2]

[Anonymous], J HEPATOL

[3] Sampling variability of liver fibrosis in chronic hepatitis C [J].

Bedossa, P ;

Dargère, D ;

Paradis, V .

HEPATOLOGY, 2003, 38 (06) :1449-1457

[4] Anti-hepatitis B virus efficacy of tendovir disoproxil fumarate in HIV-infected patients [J].

Benhamou, Y ;

Fleury, H ;

Trimoulet, P ;

Pellegrin, I ;

Urbinelli, R ;

Katlama, C ;

Rozenbaum, W ;

Le Teuff, G ;

Trylesinski, A ;

Piketty, C .

HEPATOLOGY, 2006, 43 (03) :548-555

[5] Predicting response to peginterferon α-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B [J].

Bonino, F. ;

Marcellin, P. ;

Lau, G. K. K. ;

Hadziyannis, S. ;

Jin, R. ;

Piratvisuth, T. ;

Germanidis, G. ;

Yurdaydin, C. ;

Diago, M. ;

Gurel, S. ;

Lai, M-Y ;

Brunetto, M. R. ;

Farci, P. ;

Popescu, M. ;

McCloud, P. .

GUT, 2007, 56 (05) :699-705

[6] Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis [J].

Buster, Erik H. C. J. ;

Hansen, Bettina E. ;

Buti, Maria ;

Delwaide, Jean ;

Niederau, Claus ;

Michielsen, Peter P. ;

Flisiak, Robert ;

Zondervan, Pieter E. ;

Schalm, Solko W. ;

Janssen, Harry L. A. .

HEPATOLOGY, 2007, 46 (02) :388-394

[7] Efficacy of peginterferon alpha-2b in chronic hepatitis delta:: Relevance of quantitative RT-PCR for follow-up [J].

Castelnau, Corinne ;

Le Gal, Frederic ;

Ripault, Marie-Pierre ;

Gordien, Emmanuel ;

Martinot-Peignoux, Michelle ;

Boyer, Nathalie ;

Pham, Bach-Nga ;

Maylin, Sarah ;

Bedossa, Pierre ;

Deny, Paul ;

Marcellin, Patrick ;

Gault, Elyanne .

HEPATOLOGY, 2006, 44 (03) :728-735

[8] A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B [J].

Chang, TT ;

Gish, RG ;

de Man, R ;

Gadano, A ;

Sollano, J ;

Chao, YC ;

Lok, AS ;

Han, KH ;

Goodman, Z ;

Zhu, J ;

Cross, A ;

DeHertogh, D ;

Wilber, R ;

Colonno, R ;

Apelian, D .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (10) :1001-1010

[9] Performance of the Cobas AmpliPrep/Cobas TaqMan real-time PCR assay for hepatitis B virus DNA quantification [J].

Chevaliez, Stephane ;

Bouvier-Alias, Magali ;

Laperche, Syria ;

Pawlotsky, Jean-Michel .

JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (05) :1716-1723

[10] Hepatitis B virus/hepatitis C virus coinfection: Epidemiology, clinical features, viral interactions and treatment [J].

Chu, Chi-Jen ;

Lee, Shou-Dong .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (04) :512-520

← 1 2 3 4 5 6 7 8 9 10 →